---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032553"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:55:08.109973+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ZyVersa Therapeutics induces warrant exercise for up to 12.1M shares; issues new warrants

## Summary
- Holder to exercise up to 12,121,213 existing warrants at reduced price (lower of that day's close or 5-day average) by Sep 18, 2023.
- In exchange, ZyVersa issues new warrants to purchase same number of shares, exercisable at same reduced price starting 6 months after issuance for 5 years.
- New warrants are unregistered, issued under Section 4(a)(2); existing warrant shares are registered.
- A.G.P./Alliance Global Partners acts as financial advisor with 6% fee on gross proceeds.
- Beneficial ownership blocker set at 4.99% or 9.99% per holder election.

## SEC filing metadata
- accession: 0001493152-23-032553
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315223032553/0001493152-23-032553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315223032553/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032553
- JSON: https://secwatch.observer/filing/0001493152-23-032553.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.